Surrozen- Warrants (01/08/2026) EBIT

As of the most recent data (June 2026), SRZNW shows a EBIT of $-45M. That compares with $-26M in the prior-year period — down 72.0% year over year. That is below the Healthcare sector average of $22B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SRZNW's EBIT is now $-45M (was $-26M) — a 72.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Surrozen- Warrants (01/08/2026) is outperforming or lagging.

The Healthcare sector average EBIT is about $22B. Surrozen- Warrants (01/08/2026) is at $-45M, which is lower that average. That is roughly 100.2% below the sector mean. Use the comparison chart on this page to see how SRZNW stacks up against individual peers as well.

Tracking SRZNW's ebit over time shows whether Surrozen- Warrants (01/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $-45M That compares with $-26M in the prior-year period — down 72.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Surrozen- Warrants (01/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-45M) with ownership activity and broader fundamentals.